Fig. 2From: Molecular targeted therapy for the treatment of gastric cancerMechanism of molecular targeted therapy in gastric cancer. Molecular targeted therapy acts on various mechanisms of gastric cancer, such as EGFR, angiogenesis, PDGF, IGF-1R, key enzymes or c-Met, and thus activates related signaling pathways to promote cell proliferation, differentiation, invasion and suppress apoptosis. Abbreviations: VEGFR, vascular endothelial growth factor receptor; PDGFR, platelet-derived growth factor receptor; IGF-1R, insulin-like growth factor 1 receptor; FGFR, fibroblast growth factor receptorBack to article page